All

Best Practices in Pediatric Aerosol Therapy

Nebulizing medication for pediatric patients is an effective maintenance therapy for chronic lung conditions like asthma or cystic fibrosis; and yet medication adherence remains a major concern.

All

Investigational Monoclonal Antibody Tezepelumab Is Effective Treatment for Asthma, Study Says

Tezepelumab is an effective therapy for severe asthma in patients with and without allergies, a new study found.

All

A New Understanding of Asthma Medicines

Research into common asthma aerosol treatments could improve therapeutics in the future, according to a study published in European Journal of Pharmaceutics and Biopharmaceutics.

Global Study Reveals Asthma Demographics

by RT Staff | Jan 3, 2020 | Asthma, Disorders & Diseases | 0

A survey published in CHEST shows demographic data and clinical characteristics of asthma patients.

Children With Asthma at Risk for Pneumococcal Disease

by RT Staff | Dec 20, 2019 | Asthma, Chronic Pulmonary Disorders, Disorders & Diseases, Infectious Diseases, Pediatrics | 0

Children with asthma are at much greater risk for invasive pneumococcal disease (IPD), even if they have received the pneumococcal conjugate vaccine (PCV), a systematic review and meta-analysis have found.

Novartis Drops Asthma Drug Fevipiprant After Trial Failures

by RT Staff | Dec 16, 2019 | Asthma, Chronic Pulmonary Disorders, Clinical, Disorders & Diseases | 0

Swiss drugmaker Novartis on Monday said it is jettisoning what it had hoped would be a billion-dollar-selling asthma drug, fevipiprant, from its development program after the medicine failed another set of key trials.

10 Tips to Reduce Unnecessary Pediatric MDI and Aerosol Treatments

by RT Staff | Nov 1, 2019 | Asthma, Clinical, Cystic fibrosis, Other Chronic Diseases, Pediatric Care | 0

Chronic lung conditions such as asthma require aerosolized pharmacological maintenance therapy, but data suggests the frequency and dosages can often be overprescribed and based on empirical assumptions rather than clinical evidence.

Asthma Patients Could Slash Their Carbon Footprint by Switching to ‘Greener’ Inhalers

by RT Staff | Oct 31, 2019 | Asthma | 0

Asthma patients could sharply reduce their carbon footprint by swapping commonly used...

Abruptly Changing Child’s Asthma Inhaler May Reduce Lung Function

by RT Staff | Oct 16, 2019 | Asthma, Medicare & Medicaid, Pediatric Care, Pediatrics | 0

Children with asthma who are required to switch inhaler types to accommodate insurance formulary changes may experience a loss of lung function not seen in children whose inhaler type stayed the same.

Triple Combo Inhaler Had Positive Asthma Results

by RT Staff | Oct 15, 2019 | Asthma, Business News, Pharmaceuticals | 0

In patients with uncontrolled asthma, a LAMA combined with an ICS and LABA in a single inhaler improved FEV1 and reduced exacerbations, according to data presented at ERS 2019.